You are here

A&G PHARMACEUTICAL, INC.

Company Information
Address
9130 RED BRANCH RD STE X
COLUMBIA, MD 21045-2006
United States


http://www.agpharma.com

Information

UEI: SN6SWFABJXL1

# of Employees: 27


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Pharmacology and human Phase 1 safety and dose escalation studies using anti-GP88 in aggressive breast cancer

    Amount: $1,889,054.00

    In 2017, ~200,000 new cases of breast cancer (BC) and ~40,000 related deaths are expected in the US. ~30,000 of these are patients with aggressive triple negative BC (TNBC) or anti-estrogen/aromatase ...

    SBIRPhase II2020Department of Health and Human Services National Institutes of Health
  2. A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer

    Amount: $1,313,828.00

    Cost-effective and minimally invasive monitoring of metastatic breast cancer (MBC) patients for disease progression or response to therapy is an unmet need in the clinical management of the disease. I ...

    SBIRPhase II2018Department of Health and Human Services National Institutes of Health
  3. Pharmacology & human Phase 1 safety & dose escalation studies using anti-GP88 in aggressive breast cancer

    Amount: $159,365.00

    Innew cases of breast cancerBCandrelated deaths are expected in the USof these are patients with aggressive triple negative BCTNBCor anti estrogen aromatase inhibitor resistantAE AIBC that do not have ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  4. A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer

    Amount: $152,589.00

    Significance Despite decreases in the overall number of new breast cancer BC cases reported in the US annually there are still about BC deaths annually from metastatic breast cancer ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  5. Targeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safety and dose escalation studies

    Amount: $1,988,100.00

    SignificanceInnew cases of LC andrelated deaths are expected in the USOf new LC casesare non small cell lung cancerNSCLCandof these are diagnosed with metastaticlocally advancedinoperable LC with ayr ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  6. IGF OT IGF SMART FUSION HIGH AFFINITY PEPTIDE CAPTURE REAGENTS

    Amount: $1,000,000.00

    Not Available

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health
  7. Title: Development of Novel Anticancer Agent to potentiate sensitivity to anti-estrogen therapy PoP: 09/19/2014 to 09/18/2016

    Amount: $1,478,552.00

    Not Available

    SBIRPhase II2014Department of Health and Human Services National Institutes of Health
  8. IGF::OT::IGF Title: SMART Fusion: High Affinity Peptide Capture Reagents PoP: 0

    Amount: $199,828.00

    The purpose of this application is to develop realiable, renewable, cost effective, specific, high affinity antipeptide affitnity reagent to be successfully used in mass spec based cancer biomarker de ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
  9. Targeted Therapy for Non Small Cell Lung Carcinoma: In vivo Feasibility Studies

    Amount: $193,879.00

    DESCRIPTION (provided by applicant): Lung Cancer remains the leading cause of cancer and mortality for men and women worldwide. In 2010, there were 222,520 new cases of lung cancer diagnosed in t ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
  10. NOVEL AGENT TO RESTORE SENSITIVITY TO ANTI-ESTROGEN THERAPY

    Amount: $199,380.00

    Aromatase Inhibitors (AI) are the preferred hormonal treatment for estrogen receptor positive Breast Cancer (BC) in postmenopausal women and are used to treat approximately 140,000 patients annually i ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government